In an open letter, Health and Human Services employees asked the Secretary to stop and disavow the spread of health misinformation, particularly about vaccines, infectious diseases and federal health ...

The delays, first revealed in Regeron’s Q2 report, were chalked up to manufacturing issues at Novo Nordisk-owned plants.

Looking for a biopharma job in Massachusetts? Check out the BioSpace list of nine companies hiring life sciences professionals like you.

Capricor Therapeutics met with the FDA last week for a type A meeting, during which CEO Linda Marbán aimed to explain to the ...

The FDA recommends that companies use overall survival as a primary endpoint for clinical trials where feasible. The new ...

In late May, a patient died after receiving Rocket Pharmaceuticals' investigational gene therapy for Danon disease, spurring ...

VantAI will use its machine learning capabilities to identify novel target-effector pairs that Halda can use in designing its ...

With its structural changes, CSL expects to generate $500 to $550 million in annualized savings over the next three years.

The platform strategy of using one molecule to target an underlying biological pathway to address many different diseases can ...

Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.

A draft copy of an upcoming MAHA report reveals a strategy in lockstep with recent HHS actions such as reviving the Task ...